sumatriptan has been researched along with Memory Disorders in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Changes in migraine pain severity, clinical disability, and percent effectiveness following treatment with sumatriptan nasal spray, 20 mg, were significantly correlated with cognitive function measures across all subtests (P<." | 2.70 | Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study. ( Batenhorst, A; Bleiberg, J; Cady, R; Farmer, K; O'Quinn, S; Putnam, G; Reeves, D, 2001) |
| "Sumatriptan is a 5-HT1B/1D receptor agonist used for the treatment of cluster headaches and migraine which might cause memory impairment as a potential side effect." | 1.43 | Protective Effects of Lithium on Sumatriptan-Induced Memory Impairment in Mice. ( Behestani, S; Dehpour, AR; Javadi-Paydar, M; Nikoui, V; Salehi, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikoui, V | 1 |
| Javadi-Paydar, M | 1 |
| Salehi, M | 1 |
| Behestani, S | 1 |
| Dehpour, AR | 1 |
| Farmer, K | 1 |
| Cady, R | 1 |
| Bleiberg, J | 1 |
| Reeves, D | 1 |
| Putnam, G | 1 |
| O'Quinn, S | 1 |
| Batenhorst, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Evaluation of Treximet in the Treatment of Acute Migraine Headache: A Placebo-Controlled, Double-Blind, Crossover Study, Assessing Cognitive Function.[NCT00837044] | 30 participants (Anticipated) | Interventional | 2009-02-28 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sumatriptan and Memory Disorders
| Article | Year |
|---|---|
Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
Topics: Acute Disease; Administration, Intranasal; Adult; Cognition; Cognition Disorders; Female; Humans; Me | 2001 |
1 other study available for sumatriptan and Memory Disorders
| Article | Year |
|---|---|
Protective Effects of Lithium on Sumatriptan-Induced Memory Impairment in Mice.
Topics: Animals; Lithium; Male; Memory; Memory Disorders; Mice; Receptor, Serotonin, 5-HT1B; Sumatriptan | 2016 |